Your session is about to expire
← Back to Search
MANAGE-VT Patients for Ventricular Tachycardia (MANAGE-VT Trial)
N/A
Recruiting
Research Sponsored by CorVita Science Foundation
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up july 20, 2020 - present
Awards & highlights
Summary
Data collection registry for patients with ventricular tachycardia to help physicians give better care for patients clinically and procedurally.
Eligible Conditions
- Ventricular Tachycardia
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ july 20, 2020 - present
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~july 20, 2020 - present
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Number of Participants with Risk of Sudden Cardiac Death
Prevent Risk of Stroke
Recurrence of Ventricular Tachycardia
Trial Design
1Treatment groups
Experimental Treatment
Group I: MANAGE-VT PatientsExperimental Treatment6 Interventions
Patients will be assessed on the status of their ventricular tachycardia as well as other criteria such as: EKG,
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
ICD Implant
2005
N/A
~40
Antiarrhythmic drug
2017
Completed Phase 4
~730
Cardioversion
2017
N/A
~460
Echocardiogram
2016
Completed Phase 2
~1910
Find a Location
Who is running the clinical trial?
CorVita Science FoundationLead Sponsor
1 Previous Clinical Trials
1,000 Total Patients Enrolled
Share this study with friends
Copy Link
Messenger